Solomon Islands

Solomon Islands

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.33 (4.87 - 7.42) 2019 Modelled IHME
6.45 (4.90 - 7.49) 2018 Modelled IHME
6.58 (4.83 - 7.74) 2017 Modelled IHME
6.7 (4.81 - 7.91) 2016 Modelled IHME
6.84 (4.70 - 8.24) 2015 Modelled IHME
7.01 (4.78 - 8.45) 2014 Modelled IHME
7.21 (4.97 - 8.63) 2013 Modelled IHME
7.43 (5.21 - 8.84) 2012 Modelled IHME
7.65 (5.45 - 9.10) 2011 Modelled IHME
7.87 (5.61 - 9.37) 2010 Modelled IHME
8.1 (5.79 - 9.63) 2009 Modelled IHME
8.37 (5.96 - 9.92) 2008 Modelled IHME
8.63 (6.09 - 10.22) 2007 Modelled IHME
8.85 (6.19 - 10.55) 2006 Modelled IHME
9.02 (6.21 - 10.87) 2005 Modelled IHME
9.13 (6.26 - 11.03) 2004 Modelled IHME
9.21 (6.28 - 11.09) 2003 Modelled IHME
9.28 (6.30 - 11.21) 2002 Modelled IHME
9.37 (6.30 - 11.42) 2001 Modelled IHME
9.48 (6.32 - 11.76) 2000 Modelled IHME
9.67 (6.46 - 11.92) 1999 Modelled IHME
9.94 (6.69 - 12.22) 1998 Modelled IHME
10.26 (6.94 - 12.57) 1997 Modelled IHME
10.58 (7.14 - 12.99) 1996 Modelled IHME
10.88 (7.26 - 13.41) 1995 Modelled IHME
11.15 (7.37 - 13.78) 1994 Modelled IHME
11.42 (7.43 - 14.09) 1993 Modelled IHME
11.69 (7.46 - 14.57) 1992 Modelled IHME
11.96 (7.49 - 14.95) 1991 Modelled IHME
12.23 (7.49 - 15.48) 1990 Modelled IHME
10.91 (9 - 13.18) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.29 (0.67 - 1.78) 2019 Modelled IHME
1.34 (0.68 - 1.81) 2018 Modelled IHME
1.4 (0.68 - 1.92) 2017 Modelled IHME
1.45 (0.64 - 2) 2016 Modelled IHME
1.51 (0.58 - 2.15) 2015 Modelled IHME
1.58 (0.61 - 2.27) 2014 Modelled IHME
1.66 (0.66 - 2.39) 2013 Modelled IHME
1.74 (0.73 - 2.48) 2012 Modelled IHME
1.83 (0.80 - 2.61) 2011 Modelled IHME
1.92 (0.86 - 2.73) 2010 Modelled IHME
2.03 (0.92 - 2.88) 2009 Modelled IHME
2.16 (0.98 - 3.05) 2008 Modelled IHME
2.29 (1.04 - 3.20) 2007 Modelled IHME
2.39 (1.08 - 3.33) 2006 Modelled IHME
2.45 (1.11 - 3.39) 2005 Modelled IHME
2.47 (1.13 - 3.43) 2004 Modelled IHME
2.48 (1.13 - 3.45) 2003 Modelled IHME
2.49 (1.14 - 3.46) 2002 Modelled IHME
2.5 (1.15 - 3.53) 2001 Modelled IHME
2.5 (1.17 - 3.52) 2000 Modelled IHME
2.51 (1.17 - 3.53) 1999 Modelled IHME
2.52 (1.18 - 3.52) 1998 Modelled IHME
2.52 (1.20 - 3.53) 1997 Modelled IHME
2.53 (1.20 - 3.57) 1996 Modelled IHME
2.55 (1.20 - 3.63) 1995 Modelled IHME
2.66 (1.25 - 3.79) 1994 Modelled IHME
2.93 (1.37 - 4.18) 1993 Modelled IHME
3.32 (1.53 - 4.74) 1992 Modelled IHME
3.78 (1.71 - 5.44) 1991 Modelled IHME
4.29 (1.93 - 6.24) 1990 Modelled IHME
3.1 (2 - 4.90) 2016 Survey/reported WHO WPRO, Woodring J et al, 2017
2.93 (2.02 - 3.98) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
41,624 (25,500 - 52,712) 1990 Modelled IHME
42,020 (26,319 - 52,535) 1991 Modelled IHME
42,346 (27,037 - 52,783) 1992 Modelled IHME
42,610 (27,743 - 52,595) 1993 Modelled IHME
42,813 (28,328 - 52,941) 1994 Modelled IHME
42,962 (28,687 - 52,964) 1995 Modelled IHME
42,948 (29,001 - 52,725) 1996 Modelled IHME
42,747 (28,916 - 52,405) 1997 Modelled IHME
42,508 (28,623 - 52,257) 1998 Modelled IHME
42,393 (28,324 - 52,260) 1999 Modelled IHME
42,583 (28,374 - 52,830) 2000 Modelled IHME
43,066 (28,950 - 52,500) 2001 Modelled IHME
43,656 (29,646 - 52,700) 2002 Modelled IHME
44,274 (30,186 - 53,325) 2003 Modelled IHME
44,834 (30,759 - 54,180) 2004 Modelled IHME
45,243 (31,153 - 54,540) 2005 Modelled IHME
45,329 (31,696 - 53,999) 2006 Modelled IHME
45,069 (31,845 - 53,395) 2007 Modelled IHME
44,602 (31,788 - 52,876) 2008 Modelled IHME
44,074 (31,473 - 52,388) 2009 Modelled IHME
43,643 (31,138 - 51,959) 2010 Modelled IHME
43,270 (30,802 - 51,484) 2011 Modelled IHME
42,839 (30,022 - 50,965) 2012 Modelled IHME
42,403 (29,227 - 50,750) 2013 Modelled IHME
42,019 (28,628 - 50,621) 2014 Modelled IHME
41,752 (28,701 - 50,267) 2015 Modelled IHME
41,658 (29,860 - 49,172) 2016 Modelled IHME
41,617 (30,557 - 48,977) 2017 Modelled IHME
41,550 (31,573 - 48,210) 2018 Modelled IHME
41,508 (31,934 - 48,640) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.04 (6.63 - 12.10) 2019 Modelled IHME
9.05 (6.63 - 12.20) 2018 Modelled IHME
9.22 (6.77 - 12.40) 2017 Modelled IHME
9.41 (6.96 - 12.50) 2016 Modelled IHME
9.51 (7.06 - 12.50) 2015 Modelled IHME
9.55 (7.04 - 12.60) 2014 Modelled IHME
9.51 (7.04 - 12.40) 2013 Modelled IHME
9.5 (7 - 12.50) 2012 Modelled IHME
9.45 (7.01 - 12.50) 2011 Modelled IHME
9.27 (6.81 - 12.30) 2010 Modelled IHME
9.33 (6.86 - 12.40) 2009 Modelled IHME
9.15 (6.81 - 12.20) 2008 Modelled IHME
9.45 (6.97 - 12.60) 2007 Modelled IHME
9.48 (6.80 - 12.60) 2006 Modelled IHME
9.45 (6.76 - 12.60) 2005 Modelled IHME
9.48 (6.88 - 12.50) 2004 Modelled IHME
9.57 (6.95 - 12.70) 2003 Modelled IHME
9.66 (6.88 - 12.70) 2002 Modelled IHME
9.84 (7.02 - 13.10) 2001 Modelled IHME
10 (7.14 - 13.40) 2000 Modelled IHME
10.3 (7.26 - 13.80) 1999 Modelled IHME
10.6 (7.48 - 14) 1998 Modelled IHME
10.9 (7.66 - 14.40) 1997 Modelled IHME
11.1 (7.85 - 14.70) 1996 Modelled IHME
11.3 (7.90 - 15) 1995 Modelled IHME
11.4 (7.93 - 15.30) 1994 Modelled IHME
11.6 (8.10 - 15.50) 1993 Modelled IHME
11.8 (8.02 - 16.10) 1992 Modelled IHME
12 (8.29 - 16.60) 1991 Modelled IHME
12.2 (8.27 - 17.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
59 (43 - 80) 2019 Modelled IHME
58 (43 - 78) 2018 Modelled IHME
58 (43 - 78) 2017 Modelled IHME
58 (43 - 78) 2016 Modelled IHME
58 (43 - 76) 2015 Modelled IHME
57 (42 - 75) 2014 Modelled IHME
56 (41 - 73) 2013 Modelled IHME
55 (40 - 72) 2012 Modelled IHME
53 (40 - 71) 2011 Modelled IHME
51 (38 - 68) 2010 Modelled IHME
51 (37 - 68) 2009 Modelled IHME
49 (36 - 65) 2008 Modelled IHME
49 (36 - 66) 2007 Modelled IHME
49 (35 - 64) 2006 Modelled IHME
47 (34 - 63) 2005 Modelled IHME
47 (34 - 62) 2004 Modelled IHME
46 (33 - 61) 2003 Modelled IHME
45 (32 - 60) 2002 Modelled IHME
45 (32 - 60) 2001 Modelled IHME
45 (32 - 60) 2000 Modelled IHME
45 (32 - 60) 1999 Modelled IHME
45 (32 - 60) 1998 Modelled IHME
45 (32 - 60) 1997 Modelled IHME
45 (32 - 60) 1996 Modelled IHME
45 (31 - 59) 1995 Modelled IHME
44 (30 - 59) 1994 Modelled IHME
43 (30 - 58) 1993 Modelled IHME
43 (29 - 58) 1992 Modelled IHME
42 (29 - 58) 1991 Modelled IHME
42 (28 - 59) 1990 Modelled IHME
51 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
54 (46 - 62) 2019 Modelled IHME
54 (46 - 62) 2018 Modelled IHME
54 (46 - 63) 2017 Modelled IHME
55 (47 - 63) 2016 Modelled IHME
54 (46 - 63) 2015 Modelled IHME
55 (46 - 63) 2014 Modelled IHME
54 (46 - 63) 2013 Modelled IHME
54 (46 - 63) 2012 Modelled IHME
54 (46 - 63) 2011 Modelled IHME
54 (46 - 63) 2010 Modelled IHME
54 (46 - 63) 2009 Modelled IHME
54 (46 - 63) 2008 Modelled IHME
54 (46 - 62) 2007 Modelled IHME
54 (46 - 63) 2006 Modelled IHME
54 (46 - 62) 2005 Modelled IHME
54 (46 - 63) 2004 Modelled IHME
54 (46 - 62) 2003 Modelled IHME
54 (46 - 62) 2002 Modelled IHME
54 (46 - 63) 2001 Modelled IHME
54 (46 - 63) 2000 Modelled IHME
55 (47 - 64) 1999 Modelled IHME
55 (47 - 64) 1998 Modelled IHME
56 (48 - 65) 1997 Modelled IHME
57 (48 - 65) 1996 Modelled IHME
57 (48 - 65) 1995 Modelled IHME
57 (49 - 65) 1994 Modelled IHME
57 (49 - 66) 1993 Modelled IHME
57 (49 - 66) 1992 Modelled IHME
57 (49 - 66) 1991 Modelled IHME
57 (49 - 66) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
67 2018 Survey/reported WHO/UNICEF
67 2017 Survey/reported WHO/UNICEF
67 2016 Survey/reported WHO/UNICEF
65 2015 Survey/reported WHO/UNICEF
62 2014 Survey/reported WHO/UNICEF
58 2013 Survey/reported WHO/UNICEF
59 2012 Survey/reported WHO/UNICEF
61 2011 Survey/reported WHO/UNICEF
62 2010 Survey/reported WHO/UNICEF
71 2009 Survey/reported WHO/UNICEF
80 2008 Survey/reported WHO/UNICEF
83 2007 Survey/reported WHO/UNICEF
81 2006 Survey/reported WHO/UNICEF
80 2005 Survey/reported WHO/UNICEF
78 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
73 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
66 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
85 2018 Survey/reported WHO/UNICEF
83 2017 Survey/reported WHO/UNICEF
94 2016 Survey/reported WHO/UNICEF
87 2015 Survey/reported WHO/UNICEF
77 2014 Survey/reported WHO/UNICEF
83 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
92 2011 Survey/reported WHO/UNICEF
87 2010 Survey/reported WHO/UNICEF
91 2009 Survey/reported WHO/UNICEF
89 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
83 2005 Survey/reported WHO/UNICEF
81 2004 Survey/reported WHO/UNICEF
79 2003 Survey/reported WHO/UNICEF
75 2002 Survey/reported WHO/UNICEF
83 2001 Survey/reported WHO/UNICEF
81 2000 Survey/reported WHO/UNICEF
79 1999 Survey/reported WHO/UNICEF
75 1998 Survey/reported WHO/UNICEF
73 1997 Survey/reported WHO/UNICEF
97 1996 Survey/reported WHO/UNICEF
68 1995 Survey/reported WHO/UNICEF
65 1994 Survey/reported WHO/UNICEF
53 1993 Survey/reported WHO/UNICEF
94 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.37 (0.29 - 0.46) 2019 Modelled IHME
0.37 (0.29 - 0.45) 2018 Modelled IHME
0.37 (0.29 - 0.45) 2017 Modelled IHME
0.37 (0.30 - 0.45) 2016 Modelled IHME
0.37 (0.30 - 0.46) 2015 Modelled IHME
0.37 (0.30 - 0.46) 2014 Modelled IHME
0.37 (0.30 - 0.46) 2013 Modelled IHME
0.38 (0.30 - 0.46) 2012 Modelled IHME
0.38 (0.30 - 0.46) 2011 Modelled IHME
0.38 (0.30 - 0.47) 2010 Modelled IHME
0.38 (0.30 - 0.47) 2009 Modelled IHME
0.38 (0.30 - 0.47) 2008 Modelled IHME
0.38 (0.30 - 0.47) 2007 Modelled IHME
0.38 (0.30 - 0.47) 2006 Modelled IHME
0.38 (0.30 - 0.47) 2005 Modelled IHME
0.38 (0.30 - 0.46) 2004 Modelled IHME
0.37 (0.29 - 0.46) 2003 Modelled IHME
0.36 (0.28 - 0.44) 2002 Modelled IHME
0.35 (0.27 - 0.43) 2001 Modelled IHME
0.34 (0.27 - 0.41) 2000 Modelled IHME
0.32 (0.26 - 0.40) 1999 Modelled IHME
0.31 (0.24 - 0.38) 1998 Modelled IHME
0.29 (0.23 - 0.36) 1997 Modelled IHME
0.28 (0.22 - 0.34) 1996 Modelled IHME
0.27 (0.22 - 0.33) 1995 Modelled IHME
0.27 (0.21 - 0.33) 1994 Modelled IHME
0.26 (0.21 - 0.33) 1993 Modelled IHME
0.26 (0.21 - 0.32) 1992 Modelled IHME
0.26 (0.21 - 0.32) 1991 Modelled IHME
0.26 (0.21 - 0.32) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
881 (705 - 1,091) 1990 Modelled IHME
911 (728 - 1,129) 1991 Modelled IHME
945 (758 - 1,173) 1992 Modelled IHME
981 (792 - 1,217) 1993 Modelled IHME
1,021 (822 - 1,272) 1994 Modelled IHME
1,064 (855 - 1,320) 1995 Modelled IHME
1,124 (907 - 1,384) 1996 Modelled IHME
1,209 (966 - 1,496) 1997 Modelled IHME
1,310 (1,044 - 1,618) 1998 Modelled IHME
1,413 (1,126 - 1,752) 1999 Modelled IHME
1,506 (1,194 - 1,859) 2000 Modelled IHME
1,593 (1,264 - 1,961) 2001 Modelled IHME
1,685 (1,332 - 2,080) 2002 Modelled IHME
1,773 (1,407 - 2,192) 2003 Modelled IHME
1,849 (1,471 - 2,280) 2004 Modelled IHME
1,902 (1,512 - 2,343) 2005 Modelled IHME
1,941 (1,547 - 2,388) 2006 Modelled IHME
1,978 (1,578 - 2,433) 2007 Modelled IHME
2,015 (1,609 - 2,480) 2008 Modelled IHME
2,052 (1,634 - 2,529) 2009 Modelled IHME
2,089 (1,660 - 2,584) 2010 Modelled IHME
2,127 (1,700 - 2,625) 2011 Modelled IHME
2,164 (1,725 - 2,663) 2012 Modelled IHME
2,201 (1,758 - 2,711) 2013 Modelled IHME
2,236 (1,790 - 2,749) 2014 Modelled IHME
2,271 (1,818 - 2,792) 2015 Modelled IHME
2,293 (1,838 - 2,823) 2016 Modelled IHME
2,319 (1,851 - 2,870) 2017 Modelled IHME
2,362 (1,876 - 2,918) 2018 Modelled IHME
2,412 (1,906 - 2,987) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.76 (4.01 - 7.98) 2019 Modelled IHME
5.74 (3.97 - 7.96) 2018 Modelled IHME
5.81 (4.03 - 7.98) 2017 Modelled IHME
5.84 (4.06 - 8.04) 2016 Modelled IHME
5.84 (4.07 - 8.03) 2015 Modelled IHME
5.85 (4.08 - 7.96) 2014 Modelled IHME
5.8 (4.07 - 7.95) 2013 Modelled IHME
5.77 (4.07 - 7.84) 2012 Modelled IHME
5.73 (4.03 - 7.76) 2011 Modelled IHME
5.6 (3.96 - 7.61) 2010 Modelled IHME
5.63 (3.98 - 7.70) 2009 Modelled IHME
5.52 (3.89 - 7.61) 2008 Modelled IHME
5.7 (4.01 - 7.81) 2007 Modelled IHME
5.72 (4.07 - 7.81) 2006 Modelled IHME
5.7 (3.97 - 7.70) 2005 Modelled IHME
5.68 (4 - 7.71) 2004 Modelled IHME
5.68 (3.96 - 7.78) 2003 Modelled IHME
5.65 (3.90 - 7.71) 2002 Modelled IHME
5.66 (3.86 - 7.73) 2001 Modelled IHME
5.65 (3.89 - 7.81) 2000 Modelled IHME
5.59 (3.84 - 7.75) 1999 Modelled IHME
5.48 (3.76 - 7.66) 1998 Modelled IHME
5.34 (3.66 - 7.46) 1997 Modelled IHME
5.23 (3.55 - 7.39) 1996 Modelled IHME
5.2 (3.53 - 7.32) 1995 Modelled IHME
5.22 (3.53 - 7.39) 1994 Modelled IHME
5.25 (3.51 - 7.44) 1993 Modelled IHME
5.3 (3.55 - 7.56) 1992 Modelled IHME
5.35 (3.59 - 7.73) 1991 Modelled IHME
5.38 (3.57 - 7.85) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
38 (26 - 52) 2019 Modelled IHME
37 (26 - 51) 2018 Modelled IHME
37 (26 - 50) 2017 Modelled IHME
36 (25 - 50) 2016 Modelled IHME
36 (25 - 49) 2015 Modelled IHME
35 (24 - 48) 2014 Modelled IHME
34 (24 - 47) 2013 Modelled IHME
33 (23 - 45) 2012 Modelled IHME
32 (23 - 44) 2011 Modelled IHME
31 (22 - 42) 2010 Modelled IHME
31 (22 - 42) 2009 Modelled IHME
29 (21 - 41) 2008 Modelled IHME
30 (21 - 41) 2007 Modelled IHME
29 (21 - 40) 2006 Modelled IHME
29 (20 - 39) 2005 Modelled IHME
28 (20 - 38) 2004 Modelled IHME
27 (19 - 37) 2003 Modelled IHME
27 (18 - 36) 2002 Modelled IHME
26 (18 - 36) 2001 Modelled IHME
25 (17 - 35) 2000 Modelled IHME
25 (17 - 34) 1999 Modelled IHME
23 (16 - 33) 1998 Modelled IHME
22 (15 - 31) 1997 Modelled IHME
21 (14 - 30) 1996 Modelled IHME
21 (14 - 29) 1995 Modelled IHME
20 (14 - 28) 1994 Modelled IHME
20 (13 - 28) 1993 Modelled IHME
19 (13 - 27) 1992 Modelled IHME
19 (13 - 27) 1991 Modelled IHME
18 (12 - 27) 1990 Modelled IHME
4 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
17 (12 - 23) 2019 Modelled IHME
17 (12 - 23) 2018 Modelled IHME
17 (11 - 23) 2017 Modelled IHME
17 (11 - 23) 2016 Modelled IHME
17 (11 - 23) 2015 Modelled IHME
17 (11 - 23) 2014 Modelled IHME
17 (11 - 23) 2013 Modelled IHME
17 (11 - 23) 2012 Modelled IHME
17 (11 - 23) 2011 Modelled IHME
17 (11 - 23) 2010 Modelled IHME
17 (11 - 23) 2009 Modelled IHME
17 (11 - 22) 2008 Modelled IHME
17 (11 - 23) 2007 Modelled IHME
17 (11 - 23) 2006 Modelled IHME
17 (11 - 23) 2005 Modelled IHME
17 (11 - 23) 2004 Modelled IHME
17 (11 - 23) 2003 Modelled IHME
17 (11 - 23) 2002 Modelled IHME
17 (11 - 23) 2001 Modelled IHME
17 (11 - 23) 2000 Modelled IHME
17 (11 - 23) 1999 Modelled IHME
17 (11 - 23) 1998 Modelled IHME
17 (11 - 23) 1997 Modelled IHME
16 (11 - 23) 1996 Modelled IHME
16 (11 - 23) 1995 Modelled IHME
16 (11 - 23) 1994 Modelled IHME
16 (10 - 23) 1993 Modelled IHME
16 (10 - 23) 1992 Modelled IHME
16 (10 - 23) 1991 Modelled IHME
16 (10 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
59
2019
(43 - 80)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
38
2019
(26 - 52)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
66 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners